30.08.2011 • News

Richard DeLuca Named President, Merck Animal Health

Merck & Co. said it appointed Richard DeLuca Jr. as executive vice president and president, Merck Animal Health, effective Sept. 15. DeLuca will report to Kenneth Frazier, Merck's president and chief executive, and would serve on the company's executive committee.

DeLuca is succeeding Raul Kohan, who has decided to retire from the company. Kohan will remain with the company until the end of the year. Merck noted that DeLuca would leverage the division's strong product portfolio and customer focus to capitalize on new growth opportunities, including expanding the business in emerging markets.

DeLuca has served as chief financial officer of BD Biosciences since 2010.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

From Lab to Market Challenge

Vote Now: Germany's Most Promising Chemistry Start-ups
Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Top-Feature

most read

Photo
News • Chemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.